Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brand Name Confusion Preventable Under Existing Regs, Industry Rep Says

This article was originally published in The Tan Sheet

Executive Summary

Established brand history and OTC labeling rules provide consumers with enough information to avoid confusing self-care products carrying similar brand names and different active ingredients, Consumer Healthcare Products Association General Counsel Eve Bachrach told an FDA panel June 28.
Advertisement

Related Content

FDA Drug Safety Cmte. Includes Two Specialists In Medication Mix-Ups
FDA Drug Safety Cmte. Includes Two Specialists In Medication Mix-Ups
FDA Drug Safety Cmte. Includes Two Specialists In Medication Mix-Ups
OTC Line Extensions Cause Confusion, Medical Errors, USP Members State
OTC Line Extensions Cause Confusion, Medical Errors, USP Members State

Topics

Advertisement
UsernamePublicRestriction

Register

PS091370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel